LOGIN
Tanezumab: A future option for pain control in knee osteoarthritis?
March 2013
Tanezumab: A future option for pain control in knee osteoarthritis?
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
N Engl J Med. 2010 Oct 14;363(16):1521-31.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
450 patients (age range 40 to 75) with knee osteoarthritis were randomized to receive either different dosages of the Tanezumab (an inhibitor of nerve growth factor) or a placebo, in order to determine the safety and efficacy of the Tanezumab treatment. The Tanezumab treatment group was observed to have reduced pain and improved function of the arthritic knee joint.
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.